comparemela.com

Latest Breaking News On - Serum institute of india private limited - Page 4 : comparemela.com

True North Fund announces a partial exit from PolicyBazaar

True North Fund announces a partial exit from PolicyBazaar True North sold a part of its holding in PolicyBazaar to five independent buyers – Ashoka India Equity Investment Trust Plc, Triumph Global Holdings Pte Limited, Serum Institute of India Private Limited, IIFL Special Opportunities Fund Series 8, and India Acorn Fund Limited on Friday. 0 claps sold a part of its holding in PolicyBazaar to five independent buyers – Ashoka India Equity Investment Trust Plc, Triumph Global Holdings Pte Limited, Serum Institute of India Private Limited, IIFL Special Opportunities Fund Series 8, and India Acorn Fund Limited. In October 2020, True North had conducted the first tranche of its stake sale in the company. It continues to be invested in the company for its next phase of growth. 

Experts fault NAFDAC on emergency approval for Oxford, AstraZeneca vaccine

Medical experts have disagreed on the most appropriate COVID-19 vaccine for the country as the National Agency for Food, Drug Administration and Control (NAFDAC), yesterday, gave emergency use authorisation.

NAFDAC Approves AstraZeneca COVID-19 Vaccine for Emergency Use

Onyebuchi Ezigbo in Abuja The National Agency for Food and Drug Administration and Control (NAFDAC) has approved the emergency use of AstraZeneca as COVID-19 vaccine in Nigeria. AstraZeneca, from India, is one of the two vaccines received by Nigeria and forwarded to NAFDAC for scientific study. The other one, Sputnik, developed by Russia, is still being studied by the agency. NAFDAC’s Director-General, Prof. Mojisola Adeyeye, at a press conference yesterday Abuja said the agency had evaluated the safety and efficacy of the vaccine for Nigerians. She said the vaccine could be stored in two to eight degrees Centigrade, adding that three more vaccines are being evaluated.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.